Table 2.

Estimated global exome-based prevalence of FXI deficiency by ethnicity: mutations included only if present in FXI deficiency patients in public databases

PopulationTotal no. of allelesTotal no. of carriersCollective frequency of variantsHeterozygote frequencyHomozygote/compound heterozygote frequency in 1000 individualsCalculated prevalence of FXI deficiency in 106 individuals
All 121 412 351 0.0029 0.0058 0.0084 8.4 
East Asians 8 654 39 0.0045 0.0090 0.0203 20.3 
Others 908 0.0044 0.0088 0.0194 19.4 
Europeans* 66 740 240 0.0036 0.0072 0.0129 12.9 
Latinos 11 578 24 0.0021 0.0041 0.0040 4.3 
Africans 10 406 17 0.0016 0.0033 0.0027 2.7 
South Asians 16 512 25 0.0015 0.0030 0.0023 2.3 
Finns 6 614 0.0003 0.0006 0.0001 0.1 
PopulationTotal no. of allelesTotal no. of carriersCollective frequency of variantsHeterozygote frequencyHomozygote/compound heterozygote frequency in 1000 individualsCalculated prevalence of FXI deficiency in 106 individuals
All 121 412 351 0.0029 0.0058 0.0084 8.4 
East Asians 8 654 39 0.0045 0.0090 0.0203 20.3 
Others 908 0.0044 0.0088 0.0194 19.4 
Europeans* 66 740 240 0.0036 0.0072 0.0129 12.9 
Latinos 11 578 24 0.0021 0.0041 0.0040 4.3 
Africans 10 406 17 0.0016 0.0033 0.0027 2.7 
South Asians 16 512 25 0.0015 0.0030 0.0023 2.3 
Finns 6 614 0.0003 0.0006 0.0001 0.1 

These “more conservative” carrier rates of FXI deficiency were estimated using the ExAC data set, including all null mutations plus missense variants previously reported as associated with FXI deficiency in public databases (see “Methods”).

*

Non-Finnish Europeans.

Close Modal

or Create an Account

Close Modal
Close Modal